Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

james_kehoe

Takeda appoints new chief financial officer

May 12, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, cfo, james kehoe

Takeda Pharmaceuticals has named James Kehoe its new chief financial officer. He will begin the role on June 15 2016, …
Appointment

BMS says Nice refuses backing for its immunotherapy Opdivo to treat lung cancer

May 12, 2016 Medical Communications, Research and Development, Sales and Marketing

The National Institute for Health and Care Excellence (Nice) has rejected US pharma firm Bristol-Myers Squibb’s (NYSE: BMY) immune-oncology drug …
News
lilly_entrance_web

FDA issues warning about rare, but serious, side effect in Lilly antipsychotic drug

May 12, 2016 Medical Communications, Sales and Marketing Eli Lilly, FDA, anti-psychotic, boxed warning, lilly, olanzapine, skin condition

The US Food and Drug Administration (FDA) has issued a new warning to all drug labels for Eli Lilly’s antipsychotic …
News

Nice recommends two blood tests to rule out pre-eclampsia in pregnant women

May 11, 2016 Medical Communications, Sales and Marketing NICE, Roche, regulation

The National Institute for Health and Care Excellence (Nice) has backed two blood tests to help rule-out a complication in …
News
abpi_reception_right

UK pharma would benefit by remaining in EU, says ABPI

May 9, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Andrew Witty, EU, brexit, letter, observer, pascal soriot, remain, stay

With the EU vote approaching, the Association of the British Pharmaceutical Industry (ABPI) has brought together 93 signatories, including the …
News
shutterstock_67313209

Focus: Governments evaluate policies, reforms as drug pricing debate rages on

May 9, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

By Anjali Shukla Lawmakers in France are set to urge the leaders of G7 countries to put in place guidelines …
Feature
stocks1

Weekly Movers: Bind Therapeutics, Sarepta, Idexx…

May 9, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Pfizer (NYSE: PFE) and Amgen (Nasdaq: AMGN) are rumoured to be considering a bid for Medivation just as French drug …
Feature

NICE recommends Sanofi, Amgen cholesterol drugs

May 6, 2016 Medical Communications, Sales and Marketing Amgen, Draft Guidance, NHS, NICE, Repatha, Sanofi, cardiovascular disease, cholesterol, final draft guidance, high cholesterol, praluent, recommendation, treatment

The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending two new drugs for the …
News
fda_logo-web

KemPharm’s pain drug fails to get FDA committee backing for abuse-deterrent capabilities; shares plunge

May 6, 2016 Medical Communications, Sales and Marketing

Shares in KemPharm (Nasdaq: KMPH) more than halved in pre-market trading after a US Food and Drug Administration advisory panel …
News
tug-of-war

Focus: Medivation tug-of-war rumbles on

May 6, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, AstraZeneca, Medivation, Pfizer, Sanofi, billion dollar, competition, oncology, pipeline, promising, takeover, tug of war

Medivation (NASDAQ: MDVN) has been making all the headlines as a list of suitors’ line up, all vying to secure …
Feature
merck

Merck & Co Q1 sales hurt by generics, currency impact

May 6, 2016 Medical Communications, Sales and Marketing Financial, Merck & Co, Q1, Revenye, earnings, results, sales

US pharma major Merck & Co (NYSE: MRK) posted a drop in first-quarter sales impacted the launch of generic competition …
News
papa

Valeant announces new patient access and pricing committee; vows to correct past “mistakes”

May 6, 2016 Medical Communications, Sales and Marketing Valeant, joseph papa, new committee, patient access, price gouging, pricing

Valeant (NYSE: VRX) has announced the establishment of a new patient access and pricing committee that will be responsible for …
News
pfizerbrussels

Pfizer teams up with Wave Life Sciences for metabolic disease research

May 6, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, metabolic disease, nucelic acid therapies, partnership, wave life sciences

Pfizer (NYSE: PFE) has entered into a research, license and option agreement with Wave Life Sciences (NASDAQ: WVE) for the …
News
sanofi_hq__boetie_hall

Sanofi sends letter to Medivation board; claims shareholders want takeover

May 5, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Medivation, Sanofi, board, brandicourt, hostile, shareholders, takeover

The CEO of Sanofi has issued a strongly worded letter to the board at Medivation, indicating that shareholders support their …
News
doc_writing

One in three antibiotic prescriptions in US unnecessary, says CDC

May 5, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CDC, antibiotic, prescribing, prescriptions, unnecessary

Approximately 30% of all prescriptions of antibiotics in the United States are unnecessary, according to new data published by the …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026